Legacy Edge Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Legacy Edge Advisors's AMGN Position: Q2 2026 in Review
Legacy Edge Advisors increased its Amgen (AMGN) stake by 9.9% in Q2 2026, buying an estimated $50K and bringing the position to 1,618 shares worth $452K. The position accounts for 0.06% of the portfolio, ranked #129.
Legacy Edge Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $518K in Q1 2026. 2,223 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Legacy Edge Advisors held 1,618 shares of Amgen worth $452K as of Q2 2026.
- Legacy Edge Advisors bought 146 Amgen shares in Q2 2026, an estimated $50K.
- Amgen made up 0.06% of Legacy Edge Advisors's portfolio in Q2 2026, its #129 holding.
- Legacy Edge Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- Legacy Edge Advisors's Amgen position peaked at $518K in Q1 2026.
- 2,223 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Legacy Edge Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.